Join us for a webinar hosted by the World Health Organization (WHO), Unitaid, FIND, and the STAR Initiative.

In 2021, the WHO estimated that 58 million people were living with chronic Hepatitis C virus (HCV), of which 26% knew their status and approximately one-quarter of those diagnosed received treatment. Despite recent advances in highly effective and affordable HCV treatment, many people are unaware of their status due to limited access to and low uptake of testing services and low awareness to drive demand for HCV testing in general. 

Self-testing is a vital tool to help people know their infectious disease status, offering individuals an alternative pathway to accessing treatment and effective prevention interventions. Building off the normative guidance and lessons learned from HIV self-testing, several studies have explored the acceptability, usability, and feasibility of HCV self-testing (HCVST) in various priority settings and populations.

In this 90-minute webinar, we will provide updates on HCVST for participants to learn about the most recent research results, the WHO perspective, and product market updates.